This is a sample guest message. Register a free account today to become a member! Once signed in, you'll be able to participate on this site by adding your own topics and posts, as well as connect with other members through your own private inbox!
During clinical trials, there were no reports of hearing loss from inhaled Tobi, there have been some post-market reports, but at least some of those patients were also receiving IV therapy. It seems that there is significantly less risk of ototoxicity with inhaled tobramycin. Those who have...
During clinical trials, there were no reports of hearing loss from inhaled Tobi, there have been some post-market reports, but at least some of those patients were also receiving IV therapy. It seems that there is significantly less risk of ototoxicity with inhaled tobramycin. Those who have...
During clinical trials, there were no reports of hearing loss from inhaled Tobi, there have been some post-market reports, but at least some of those patients were also receiving IV therapy. It seems that there is significantly less risk of ototoxicity with inhaled tobramycin. Those who have...
During clinical trials, there were no reports of hearing loss from inhaled Tobi, there have been some post-market reports, but at least some of those patients were also receiving IV therapy. It seems that there is significantly less risk of ototoxicity with inhaled tobramycin. Those who have...
During clinical trials, there were no reports of hearing loss from inhaled Tobi, there have been some post-market reports, but at least some of those patients were also receiving IV therapy. It seems that there is significantly less risk of ototoxicity with inhaled tobramycin. Those who have...
Well,
Genetics is a complex topic. For a while we have understood that sometimes being heterozygous dominant (genotype) does not completely mask the phenotypic expression of the recessive gene. That is, some carriers demonstrated CF like symptoms (gastric problems, sinus/allergy issues). More...
Well,
Genetics is a complex topic. For a while we have understood that sometimes being heterozygous dominant (genotype) does not completely mask the phenotypic expression of the recessive gene. That is, some carriers demonstrated CF like symptoms (gastric problems, sinus/allergy issues). More...
Well,
Genetics is a complex topic. For a while we have understood that sometimes being heterozygous dominant (genotype) does not completely mask the phenotypic expression of the recessive gene. That is, some carriers demonstrated CF like symptoms (gastric problems, sinus/allergy issues). More...
Well,
Genetics is a complex topic. For a while we have understood that sometimes being heterozygous dominant (genotype) does not completely mask the phenotypic expression of the recessive gene. That is, some carriers demonstrated CF like symptoms (gastric problems, sinus/allergy issues). More...
Well,
<br />
<br />Genetics is a complex topic. For a while we have understood that sometimes being heterozygous dominant (genotype) does not completely mask the phenotypic expression of the recessive gene. That is, some carriers demonstrated CF like symptoms (gastric problems, sinus/allergy...
This site uses cookies to help personalise content, tailor your experience and to keep you logged in if you register.
By continuing to use this site, you are consenting to our use of cookies.